UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
July 16, 2026
Accession Number:
0001193125-26-305103
Submission Type:
POS AM
CIK:
0001369568
Company Name:
CATALYST PHARMACEUTICALS, INC.
File Number:
333-170945